Universal Beteiligungs und Servicegesellschaft mbH Purchases 1,682 Shares of Chemed Corporation $CHE

Universal Beteiligungs und Servicegesellschaft mbH increased its position in Chemed Corporation (NYSE:CHE) by 29.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,348 shares of the company’s stock after purchasing an additional 1,682 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Chemed were worth $3,146,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Smartleaf Asset Management LLC grew its stake in Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after purchasing an additional 25 shares in the last quarter. First Horizon Corp bought a new position in Chemed in the third quarter worth approximately $31,000. Geneos Wealth Management Inc. grew its stake in Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares in the last quarter. Pilgrim Partners Asia Pte Ltd bought a new position in Chemed in the third quarter worth approximately $45,000. Finally, HM Payson & Co. grew its stake in Chemed by 35.5% in the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock worth $46,000 after purchasing an additional 27 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total transaction of $806,360.00. Following the sale, the chief executive officer owned 93,719 shares of the company’s stock, valued at approximately $37,785,626.42. This trade represents a 2.09% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 3.33% of the company’s stock.

Chemed Stock Up 0.3%

Shares of NYSE CHE opened at $425.20 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $5.64 billion, a PE ratio of 23.17, a price-to-earnings-growth ratio of 1.59 and a beta of 0.49. The stock’s fifty day simple moving average is $399.29 and its two-hundred day simple moving average is $426.04. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $583.96.

Chemed (NYSE:CHE) last announced its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.30 by $0.35. The business had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same quarter last year, the firm earned $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, analysts expect that Chemed Corporation will post 22.3 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Monday, February 23rd. Chemed’s dividend payout ratio (DPR) is 13.08%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday. Oppenheimer dropped their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research note on Friday, February 27th. Royal Bank Of Canada increased their price objective on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research note on Monday. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday. Finally, Jefferies Financial Group cut Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $501.50.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.